Stock UniverseDerived research view · source repositories remain read-only

Repligen Corporation (RGEN)

Life Science Tools / Diagnostics / MedTech · Healthcare / Medical Instruments & Supplies
Score Band
Qualified
Selection Score
38.09
Global Rank
682
Market Cap
7.25B
Latest Close
122.31
RS Composite
-15.87% · G#2432

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-2.74%
3M
1.93%
6M
-26.55%
1Y
-3.35%
3Y
-27.16%
5Y
-33.02%
10Y
410.48%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 672.58K · 30-day average: 1.24M · Max drawdown over stored range: -68.27%

Research Snapshot

Relative Strength vs SPX

RS Composite-15.87%
20D RS-3.89%
60D RS-6.39%
120D RS-31.34%
Global RS Rank2432 · 27.51% percentile
Qualified+ RS Rank926 · 26.39% percentile
Group ScopeQualified+
Primary RS Rank95 · 33.10% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank56 / 246
Primary Percentile77.64
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-06n/an/a64.53M51.40M3.62189.33M38.89M150.43M14Mn/an/an/an/an/a784.53M546.59M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$3.6233.8xn/an/a$10.5911.6x$13.329.2x

Shares Diluted: 14M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue366.26670.534801.536632.362634.439738.256
Revenue Growth (YoY)35.529%83.076%19.537%-21.106%0.328%16.364%
Gross Profit210.36391.254455.706308.826318.673388.712
Operating Income74.557173.114195.94149.33437.64645.695
Free Cash Flow40.1751.92787.24977.696149.71793.898
Free Cash Flow Per Share0.7450.9071.5191.3782.6771.66
EPS (Diluted) GAAP1.112.243.2433380.63-0.460.86
EPS Growth152.273%101.802%44.792%-80.576%9800%
EPS Non-GAAP
Gross Margin57.435%58.35%56.854%48.837%50.229%52.653%
Operating Margin20.356%25.817%24.446%7.802%5.934%6.19%
Profit Margin16.362%19.133%23.2%5.629%-4.022%6.623%
Free Cash Flow Margin10.968%7.744%10.885%12.287%23.598%12.719%
Shares Outstanding (Diluted)53.89257.26457.45556.37755.93756.561
Shares Change (YoY)9.523%6.257%0.334%-1.876%-0.78%1.116%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-06n/an/a15.94Mn/a8.33Mn/a0.1556.67M784.53M546.59Mprocessed
2025 Q42026-02-26n/an/a17.87Mn/a13.29Mn/a234.4056.68K767.63M542.21Mprocessed
2025 Q32025-11-04n/an/a16.82Mn/a14.91Mn/a0.2656.53K748.75M537.93Mprocessed
2025 Q22025-08-07n/an/a13.90Mn/a14.87Mn/a0.2656.51K708.86M533.70Mprocessed
2025 Q12025-04-29n/an/a6.58Mn/a5.83Mn/a0.1056.56K697.23M529.60Mprocessed
2024 Q42025-03-14n/an/a-36.50Mn/a-33.87Mn/a-618.0154.80K757.36M525.60Mprocessed
2024 Q32024-11-18n/an/a-7.83Mn/a-654.00Kn/a-0.0156.01K783.96M521.60Mprocessed
2024 Q22024-07-30n/an/a1.49Mn/a3.32Mn/a0.0656.43K809.15M69.50Mprocessed
2024 Q12024-05-01n/an/a2.03Mn/a2.09Mn/a0.0456.53K780.62M69.50Mprocessed
2023 Q42024-02-22n/an/a-887.00Kn/a-25.49Mn/a-465.8854.71K751.32M69.50Mprocessed
2023 Q32023-10-31n/an/a4.81Mn/a18.17Mn/a0.3256.94K630.78M286.00Mprocessed
2023 Q22023-08-02n/an/a19.40Mn/a20.06Mn/a0.3556.86K603.66M285.50Mprocessed
2023 Q12023-05-02n/an/a31.26Mn/a28.83Mn/a0.5157.05K516.61M285.07Mprocessed
2022 Q42023-02-22n/an/a48.84Mn/a48.73Mn/a854.5057.03K523.46M284.60Mprocessed
2022 Q32022-11-01n/an/a52.66Mn/a40.41Mn/a0.7157.30K573.36M284.20Mprocessed
2022 Q22022-08-02n/an/a63.17Mn/a49.86Mn/a0.8856.72K596.51M283.70Mprocessed
2022 Q12022-04-27n/an/a60.00Mn/a46.96Mn/a0.8158.82K584.64M283.30Kprocessed
2021 Q42022-02-17n/an/a37.43Mn/a29.11Mn/a0.5057.84M603.81M255.30Mprocessed
2021 Q32021-10-28n/an/a45.19Mn/a33.50Mn/a0.5857.37M621.10M252.30Mprocessed
2021 Q22021-07-27n/an/a48.24Mn/a36.23Mn/a0.6456.79M734.33M249.40Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.